Pub Date : 2024-09-17eCollection Date: 2024-11-01DOI: 10.1097/MS9.0000000000002509
S Taouihar, H Dergamoun, A Bouabdallaoui, Y Hadzin, A El Gdaouni, F Z Haddari, A El Mekkaoui, O Benlenda, I Ziouziou, H Nassik
Introduction and importance: The spontaneous and non-traumatic rupture of renal cysts is a rare clinical condition, which can lead to hemorrhagic shock. In this paper, the authors report a case of spontaneous rupture of a renal cyst and discuss the main features of this condition.
Case report: A 21-year-old patient presented urgently with hemorrhagic shock with no history or evidence of trauma. Physical examination revealed a swollen left lumbar fossa on palpation. Abdominal CT revealed an abundant retroperitoneal hematoma. Resuscitation measures were urgently initiated to ensure hemodynamic stabilization, followed by a hemostasis nephrectomy. The patient was stabilized, and subsequent postoperative recovery proceeded without complications. He was sent home on the seventh day following his admission.
Discussion: Spontaneous retroperitoneal hemorrhages may stem from various pathologies, including simple renal cysts, and frequently manifest with Lenk's triad. Wunderlich syndrome, an infrequent manifestation of such hemorrhages, necessitates prompt recognition and hemodynamic stabilization, with potential treatment including embolization or surgical intervention.
Conclusion: Although simple renal cysts are generally asymptomatic, they can lead to serious complications such as hemorrhage that could be life-threatening without appropriate medical intervention. The treatment involves performing an emergency nephrectomy for hemostasis, along with implementing resuscitation measures.
{"title":"A spontaneous rupture of a simple renal cyst complicated by hemorrhagic shock: a case report.","authors":"S Taouihar, H Dergamoun, A Bouabdallaoui, Y Hadzin, A El Gdaouni, F Z Haddari, A El Mekkaoui, O Benlenda, I Ziouziou, H Nassik","doi":"10.1097/MS9.0000000000002509","DOIUrl":"https://doi.org/10.1097/MS9.0000000000002509","url":null,"abstract":"<p><strong>Introduction and importance: </strong>The spontaneous and non-traumatic rupture of renal cysts is a rare clinical condition, which can lead to hemorrhagic shock. In this paper, the authors report a case of spontaneous rupture of a renal cyst and discuss the main features of this condition.</p><p><strong>Case report: </strong>A 21-year-old patient presented urgently with hemorrhagic shock with no history or evidence of trauma. Physical examination revealed a swollen left lumbar fossa on palpation. Abdominal CT revealed an abundant retroperitoneal hematoma. Resuscitation measures were urgently initiated to ensure hemodynamic stabilization, followed by a hemostasis nephrectomy. The patient was stabilized, and subsequent postoperative recovery proceeded without complications. He was sent home on the seventh day following his admission.</p><p><strong>Discussion: </strong>Spontaneous retroperitoneal hemorrhages may stem from various pathologies, including simple renal cysts, and frequently manifest with Lenk's triad. Wunderlich syndrome, an infrequent manifestation of such hemorrhages, necessitates prompt recognition and hemodynamic stabilization, with potential treatment including embolization or surgical intervention.</p><p><strong>Conclusion: </strong>Although simple renal cysts are generally asymptomatic, they can lead to serious complications such as hemorrhage that could be life-threatening without appropriate medical intervention. The treatment involves performing an emergency nephrectomy for hemostasis, along with implementing resuscitation measures.</p>","PeriodicalId":8025,"journal":{"name":"Annals of Medicine and Surgery","volume":"86 11","pages":"6753-6756"},"PeriodicalIF":1.7,"publicationDate":"2024-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11543171/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142613561","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: Breast cancer commonly occurs in women, and male breast cancer makes up less than 1% of all cases of breast cancer. The limited prevalence of male breast cancer has led to decreased attention being paid to this condition, resulting in its diagnosis occurring at later ages and at more severe disease stages.
Objectives: This study evaluates the demographic and clinicopathological characteristics of male patients diagnosed with breast cancer who visited the northern region of Iran from 1992 to 2023.
Methods: This descriptive study reviewed data from 58 cases of male breast cancer between 1992 and 2023. The study aimed to examine and describe the information connected to these patients. The data were analyzed with SPSS.22 set at P value less than 0.05.
Results: The mean age of the patients examined was 62.10±13.40 years, while their mean BMI was 27.08±4.95. The study found no statistically significant correlation between BMI with stage and kinds of recurrence, including metastasis and local recurrence (P>0.05). The right and left breast involvement rates were equal (48.28%) in 28 cases, and 2 cases (3.40%) had bilateral involvement. The bone was the predominant site of metastasis, accounting for 69.23% of cases. The analysis revealed no significant correlation between stage and metastasis (P=1.000) or local recurrence (P=0.543). Most metastasis and all the local recurrence were observed in stages 3 and 4.
Conclusion: Male breast cancer mainly occurs in older age and is diagnosed in the advanced stages of the disease. Therefore, it is recommended to inform men and develop suitable screening programs, especially in high-risk families.
{"title":"Male breast cancer: a 32-year retrospective analysis in radiation therapy referral center in northern Iran.","authors":"Mahboobeh Asgharian, Dariush Moslemi, Hossein-Ali Nikbakht, Mohammad-Ali Jahani, Ali Bijani, Hakimeh Mehdizadeh","doi":"10.1097/MS9.0000000000002571","DOIUrl":"10.1097/MS9.0000000000002571","url":null,"abstract":"<p><strong>Background: </strong>Breast cancer commonly occurs in women, and male breast cancer makes up less than 1% of all cases of breast cancer. The limited prevalence of male breast cancer has led to decreased attention being paid to this condition, resulting in its diagnosis occurring at later ages and at more severe disease stages.</p><p><strong>Objectives: </strong>This study evaluates the demographic and clinicopathological characteristics of male patients diagnosed with breast cancer who visited the northern region of Iran from 1992 to 2023.</p><p><strong>Methods: </strong>This descriptive study reviewed data from 58 cases of male breast cancer between 1992 and 2023. The study aimed to examine and describe the information connected to these patients. The data were analyzed with SPSS.22 set at <i>P</i> value less than 0.05.</p><p><strong>Results: </strong>The mean age of the patients examined was 62.10±13.40 years, while their mean BMI was 27.08±4.95. The study found no statistically significant correlation between BMI with stage and kinds of recurrence, including metastasis and local recurrence (<i>P</i>>0.05). The right and left breast involvement rates were equal (48.28%) in 28 cases, and 2 cases (3.40%) had bilateral involvement. The bone was the predominant site of metastasis, accounting for 69.23% of cases. The analysis revealed no significant correlation between stage and metastasis (<i>P</i>=1.000) or local recurrence (<i>P</i>=0.543). Most metastasis and all the local recurrence were observed in stages 3 and 4.</p><p><strong>Conclusion: </strong>Male breast cancer mainly occurs in older age and is diagnosed in the advanced stages of the disease. Therefore, it is recommended to inform men and develop suitable screening programs, especially in high-risk families.</p>","PeriodicalId":8025,"journal":{"name":"Annals of Medicine and Surgery","volume":"86 10","pages":"5756-5761"},"PeriodicalIF":1.7,"publicationDate":"2024-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11444606/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142364077","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-09-12eCollection Date: 2024-10-01DOI: 10.1097/MS9.0000000000002570
Salah Marwan Saadeldine, Yara Mohammad Alammouri
Introduction: Chronic myeloid leukemia (CML) is the most common leukemia in adults. It can present with a wide variable range of symptoms and signs related to the phase of the disease. Ophthalmic manifestations as the first presentation of CML are unique, although they can occur during any stage of the disease. Ocular lesions in CML patients may be asymptomatic, so all patients should undergo an eye evaluation at the initial diagnosis.
Case presentation: The authors report a case of a 17-year-old Syrian male who initially presented with progressive loss of vision, fatigue, and abdominal pain. Clinical examination showed bilateral retinal aneurysm hemorrhage, jaundice, and splenomegaly. Bone marrow biopsy results were consistent with the diagnosis of CML returning to AML. The patient was treated with intensive chemotherapy and then prepared for hematopoietic transplantation.
Discussion: CML can present with variable symptoms and signs, but the ophthalmic manifestations are uncommon. Ophthalmic problems occur either from infiltration of neoplastic cells or from secondary causes, like thrombocytopenia, leukocytosis, hyperviscosity syndrome, or leukoembolization. In the literature, only some case reports presented eye involvement in CML as the first manifestation.
Conclusion: Although this is a rare presentation of CML, we believe that it should be taken into consideration when managing these situations to obtain the right diagnosis and better treatment results. Collaboration between hematologists and ophthalmologists is necessary in deciding the treatment. Acute myeloid leukemia needs immediate medical attention and different treatment from CML.
{"title":"Bilateral visual loss as the initial presentation of chronic myeloid leukemia: a case report.","authors":"Salah Marwan Saadeldine, Yara Mohammad Alammouri","doi":"10.1097/MS9.0000000000002570","DOIUrl":"10.1097/MS9.0000000000002570","url":null,"abstract":"<p><strong>Introduction: </strong>Chronic myeloid leukemia (CML) is the most common leukemia in adults. It can present with a wide variable range of symptoms and signs related to the phase of the disease. Ophthalmic manifestations as the first presentation of CML are unique, although they can occur during any stage of the disease. Ocular lesions in CML patients may be asymptomatic, so all patients should undergo an eye evaluation at the initial diagnosis.</p><p><strong>Case presentation: </strong>The authors report a case of a 17-year-old Syrian male who initially presented with progressive loss of vision, fatigue, and abdominal pain. Clinical examination showed bilateral retinal aneurysm hemorrhage, jaundice, and splenomegaly. Bone marrow biopsy results were consistent with the diagnosis of CML returning to AML. The patient was treated with intensive chemotherapy and then prepared for hematopoietic transplantation.</p><p><strong>Discussion: </strong>CML can present with variable symptoms and signs, but the ophthalmic manifestations are uncommon. Ophthalmic problems occur either from infiltration of neoplastic cells or from secondary causes, like thrombocytopenia, leukocytosis, hyperviscosity syndrome, or leukoembolization. In the literature, only some case reports presented eye involvement in CML as the first manifestation.</p><p><strong>Conclusion: </strong>Although this is a rare presentation of CML, we believe that it should be taken into consideration when managing these situations to obtain the right diagnosis and better treatment results. Collaboration between hematologists and ophthalmologists is necessary in deciding the treatment. Acute myeloid leukemia needs immediate medical attention and different treatment from CML.</p>","PeriodicalId":8025,"journal":{"name":"Annals of Medicine and Surgery","volume":"86 10","pages":"6335-6339"},"PeriodicalIF":1.7,"publicationDate":"2024-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11444546/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142364101","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-09-12eCollection Date: 2024-10-01DOI: 10.1097/MS9.0000000000002569
Zaira Naisr, Abdullah Munir Ahmed, Hajira Arooj, Lava Abdullah, Zunaira Naeem, Muhammad Usman Hashmi
Introduction and importance: Rasmussen encephalitis (RE) is a rare autoimmune disorder that causes unilateral inflammation of the cerebral cortex and can lead to drug-resistant epilepsy and progressive neurological decline. Although the emergence of RE following COVID-19 has not been well documented, it emphasizes the need to understand the impact of COVID-19 on neurological health. This case emphasizes the importance of early recognition and intervention to prevent adverse outcomes related to post-COVID-19 neurological complications.
Case presentation: A 30-year-old woman, recently diagnosed with COVID-19, experienced recurrent seizures that primarily affected the left side of her body. Despite medical management, signs of progressive weakness and altered consciousness were observed. Neurological examination, imaging, and electroencephalography confirmed a diagnosis of post-COVID-19 RE. Despite conservative management, the patient's condition continued to deteriorate, ultimately resulting in fatal outcomes.
Clinical discussion: The relationship between COVID-19 and autoimmune responses, which can lead to neurological complications, such as RE, is a matter of concern. Accurate diagnosis of RE depends on imaging and EEG studies; however, a definitive diagnosis often requires histopathological examination. The management of RE involves the use of anti-seizure medications and surgical interventions to control symptoms and improve outcomes. However, the unusual presentation of this case, along with challenges in diagnosis and treatment, underscores the need for increased awareness and extensive research on the neurological consequences of COVID-19.
Conclusion: This case underscores the severe neurological consequences that can emerge after COVID-19, emphasizing the need for prompt identification and intervention. Additional research is essential to improve the comprehension and management of the neurological aftermath of COVID-19 with the ultimate goal of enhancing patient outcomes.
{"title":"Unveiling post-COVID-19 Rasmussen's encephalitis: a case report of rare neurological complication.","authors":"Zaira Naisr, Abdullah Munir Ahmed, Hajira Arooj, Lava Abdullah, Zunaira Naeem, Muhammad Usman Hashmi","doi":"10.1097/MS9.0000000000002569","DOIUrl":"10.1097/MS9.0000000000002569","url":null,"abstract":"<p><strong>Introduction and importance: </strong>Rasmussen encephalitis (RE) is a rare autoimmune disorder that causes unilateral inflammation of the cerebral cortex and can lead to drug-resistant epilepsy and progressive neurological decline. Although the emergence of RE following COVID-19 has not been well documented, it emphasizes the need to understand the impact of COVID-19 on neurological health. This case emphasizes the importance of early recognition and intervention to prevent adverse outcomes related to post-COVID-19 neurological complications.</p><p><strong>Case presentation: </strong>A 30-year-old woman, recently diagnosed with COVID-19, experienced recurrent seizures that primarily affected the left side of her body. Despite medical management, signs of progressive weakness and altered consciousness were observed. Neurological examination, imaging, and electroencephalography confirmed a diagnosis of post-COVID-19 RE. Despite conservative management, the patient's condition continued to deteriorate, ultimately resulting in fatal outcomes.</p><p><strong>Clinical discussion: </strong>The relationship between COVID-19 and autoimmune responses, which can lead to neurological complications, such as RE, is a matter of concern. Accurate diagnosis of RE depends on imaging and EEG studies; however, a definitive diagnosis often requires histopathological examination. The management of RE involves the use of anti-seizure medications and surgical interventions to control symptoms and improve outcomes. However, the unusual presentation of this case, along with challenges in diagnosis and treatment, underscores the need for increased awareness and extensive research on the neurological consequences of COVID-19.</p><p><strong>Conclusion: </strong>This case underscores the severe neurological consequences that can emerge after COVID-19, emphasizing the need for prompt identification and intervention. Additional research is essential to improve the comprehension and management of the neurological aftermath of COVID-19 with the ultimate goal of enhancing patient outcomes.</p>","PeriodicalId":8025,"journal":{"name":"Annals of Medicine and Surgery","volume":"86 10","pages":"6330-6334"},"PeriodicalIF":1.7,"publicationDate":"2024-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11444579/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142364154","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Introduction and importance: Gaucher disease is a rare autosomal recessive lysosomal storage disorder marked by a substantial reduction in beta-glucocerebrosidase activity. Historically, supportive treatments such as splenectomy and orthopedic interventions were employed, whereas recent advances have led to the approval of Enzyme Replacement Therapy (ERT) and Substrate Reduction Therapy (SRT) as therapeutic options.
Case presentation: The authors present the case of a 61-year-old female with chronic abdominal pain, abdominal fullness, pancytopenia, and hepatosplenomegaly, all indicative of Gaucher's disease, later confirmed by histopathological examination. The patient was informed about newer treatment options like ERT and SRT, as well as the traditional approach of splenectomy. However, due to financial constraints, she opted for splenectomy in conjunction with conservative management.
Discussion: Gaucher disease is defined by a deficiency of glucocerebrosidase, leading to the accumulation of Gaucher cells (pathognomonic of the disease), particularly in the spleen, liver, bone marrow, and lungs. Type 1 Gaucher disease (GD1) can manifest at any age, from childhood to late adulthood. Definitive diagnosis is confirmed by reduced beta-glucocerebrosidase activity. Traditionally, treatment options for GD1 have been supportive, including splenectomy, blood transfusions, and orthopedic procedures. However, SRT and ERT, though effective, remain prohibitively expensive and often inaccessible in low-resource settings.
Conclusion: Early diagnosis of Gaucher disease is challenging due to its rarity and should be considered in patients presenting with hepatosplenomegaly, pancytopenia, and low glucocerebrosidase activity.
{"title":"Non-neuronopathic Gaucher disease (Type I) in an elderly female: a case report.","authors":"Sujan Bohara, Sanjeet Bhattarai, Manoj Khadka, Deepak Ghimire, Samikshya Karki, Nahakul Poudel, Gopi Aryal, Sunil S Dhakal","doi":"10.1097/MS9.0000000000002566","DOIUrl":"https://doi.org/10.1097/MS9.0000000000002566","url":null,"abstract":"<p><strong>Introduction and importance: </strong>Gaucher disease is a rare autosomal recessive lysosomal storage disorder marked by a substantial reduction in beta-glucocerebrosidase activity. Historically, supportive treatments such as splenectomy and orthopedic interventions were employed, whereas recent advances have led to the approval of Enzyme Replacement Therapy (ERT) and Substrate Reduction Therapy (SRT) as therapeutic options.</p><p><strong>Case presentation: </strong>The authors present the case of a 61-year-old female with chronic abdominal pain, abdominal fullness, pancytopenia, and hepatosplenomegaly, all indicative of Gaucher's disease, later confirmed by histopathological examination. The patient was informed about newer treatment options like ERT and SRT, as well as the traditional approach of splenectomy. However, due to financial constraints, she opted for splenectomy in conjunction with conservative management.</p><p><strong>Discussion: </strong>Gaucher disease is defined by a deficiency of glucocerebrosidase, leading to the accumulation of Gaucher cells (pathognomonic of the disease), particularly in the spleen, liver, bone marrow, and lungs. Type 1 Gaucher disease (GD1) can manifest at any age, from childhood to late adulthood. Definitive diagnosis is confirmed by reduced beta-glucocerebrosidase activity. Traditionally, treatment options for GD1 have been supportive, including splenectomy, blood transfusions, and orthopedic procedures. However, SRT and ERT, though effective, remain prohibitively expensive and often inaccessible in low-resource settings.</p><p><strong>Conclusion: </strong>Early diagnosis of Gaucher disease is challenging due to its rarity and should be considered in patients presenting with hepatosplenomegaly, pancytopenia, and low glucocerebrosidase activity.</p>","PeriodicalId":8025,"journal":{"name":"Annals of Medicine and Surgery","volume":"86 11","pages":"6780-6783"},"PeriodicalIF":1.7,"publicationDate":"2024-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11543243/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142613571","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Introduction and importance: Multiple primary malignancies (MPMs) involve two or more distinct primary cancers in one individual, either simultaneously or at different times. The incidence of MPMs is rising due to advancements in cancer detection, improved survival rates, and long-term treatment effects. This case report, likely the first of its kind, highlights a rare instance of a 30-year-old female developing a carcinoid tumor 5 years after Ewing sarcoma, emphasizing the need for vigilant monitoring of cancer survivors.
Case presentation: A 30-year-old female with a history of Ewing Sarcoma diagnosed 5 years prior, initially presenting with a vascular, hard mass on her right shoulder, underwent neoadjuvant chemotherapy and surgical excision. She recently presented with high-grade fever, cough, weight loss, and severe chest pain. Imaging and biopsy confirmed a high-grade carcinoid tumor. Histopathology showed positive markers for Synaptophysin, CD56, and Chromogranin, with a Ki-67 index of 30-40%. The patient passed away after one cycle of chemotherapy.
Clinical discussion: Diagnosing and managing MPMs is challenging due to the complexity of distinguishing primary tumors from metastases. This case fits the Warren and Gates' criteria for MPMs. This case confirmed Ewing sarcoma and atypical carcinoid tumor as distinct primary malignancies. Delayed diagnosis worsens outcomes, especially for aggressive atypical carcinoids. This case underscores the importance of thorough diagnostics, long-term follow-up, and improved healthcare infrastructure.
Conclusion: This case report emphasizes the importance of a multidisciplinary approach, regular follow-ups, and timely detection for effective management of MPMs.
{"title":"Multiple primary malignancies: sequential development of Ewing sarcoma and carcinoid tumor in a single patient.","authors":"Huzafa Ali, Dipendra Adhikari, Azka Noor, Husnain Abbas, Huzaifa Saqib, Ayesha Siddiqa, Amna Khan, Nayab Naeem","doi":"10.1097/MS9.0000000000002561","DOIUrl":"10.1097/MS9.0000000000002561","url":null,"abstract":"<p><strong>Introduction and importance: </strong>Multiple primary malignancies (MPMs) involve two or more distinct primary cancers in one individual, either simultaneously or at different times. The incidence of MPMs is rising due to advancements in cancer detection, improved survival rates, and long-term treatment effects. This case report, likely the first of its kind, highlights a rare instance of a 30-year-old female developing a carcinoid tumor 5 years after Ewing sarcoma, emphasizing the need for vigilant monitoring of cancer survivors.</p><p><strong>Case presentation: </strong>A 30-year-old female with a history of Ewing Sarcoma diagnosed 5 years prior, initially presenting with a vascular, hard mass on her right shoulder, underwent neoadjuvant chemotherapy and surgical excision. She recently presented with high-grade fever, cough, weight loss, and severe chest pain. Imaging and biopsy confirmed a high-grade carcinoid tumor. Histopathology showed positive markers for Synaptophysin, CD56, and Chromogranin, with a Ki-67 index of 30-40%. The patient passed away after one cycle of chemotherapy.</p><p><strong>Clinical discussion: </strong>Diagnosing and managing MPMs is challenging due to the complexity of distinguishing primary tumors from metastases. This case fits the Warren and Gates' criteria for MPMs. This case confirmed Ewing sarcoma and atypical carcinoid tumor as distinct primary malignancies. Delayed diagnosis worsens outcomes, especially for aggressive atypical carcinoids. This case underscores the importance of thorough diagnostics, long-term follow-up, and improved healthcare infrastructure.</p><p><strong>Conclusion: </strong>This case report emphasizes the importance of a multidisciplinary approach, regular follow-ups, and timely detection for effective management of MPMs.</p>","PeriodicalId":8025,"journal":{"name":"Annals of Medicine and Surgery","volume":"86 10","pages":"6322-6325"},"PeriodicalIF":1.7,"publicationDate":"2024-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11444556/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142364092","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-09-10eCollection Date: 2024-10-01DOI: 10.1097/MS9.0000000000002564
Wajiha Urooj, Bisma Ahmed, Yumna Shahzad, Amal Siddiqui, Zaib Un Nisa Mughal, Khabab Abbasher Hussien Mohamed Ahmed
{"title":"FDA endorses NALIRIFOX for metastatic pancreatic adenocarcinoma: an editorial.","authors":"Wajiha Urooj, Bisma Ahmed, Yumna Shahzad, Amal Siddiqui, Zaib Un Nisa Mughal, Khabab Abbasher Hussien Mohamed Ahmed","doi":"10.1097/MS9.0000000000002564","DOIUrl":"10.1097/MS9.0000000000002564","url":null,"abstract":"","PeriodicalId":8025,"journal":{"name":"Annals of Medicine and Surgery","volume":"86 10","pages":"5685-5687"},"PeriodicalIF":1.7,"publicationDate":"2024-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11444624/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142364053","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-09-10eCollection Date: 2024-10-01DOI: 10.1097/MS9.0000000000002539
Reza Basiri, Farzad Sharifnezhad, Amir H Jafarian, Sara Samadi, Amirreza Zarghi
Introduction: The diagnosis of peripheral pulmonary lesions (PPL) poses a significant challenge, prompting the widespread utilization of various modalities to ensure the precision in diagnosis. This study aims to assess the diagnostic accuracy of computed tomography-guided percutaneous transthoracic needle biopsy (CT-PTNB) in the context of pulmonary malignancy.
Methods and materials: This multicenter retrospective observational study, included 1317 cases of CT-PTNB performed on adult patients with PPLs from January 2018 to December 2022 in Mashhad, Iran. The pathology results of CT-PTNB from 94 cases were compared to the definitive pathology results obtained through methods such as surgery to assess the sensitivity, specificity, and overall accuracy of CT-PTNB in diagnosing of pulmonary malignancy.
Results: CT-PTNB exhibits an accuracy of 82.98%, with sensitivity and specificity rates of 75.41 and 91.43%, respectively. This study underscores the issue of false-negative results in CT-PTNB and underscores the importance of integrating clinical, radiological, and additional diagnostic modality to guide diagnostic decisions.
Conclusion: In this large-scale multicenter study, the accuracy of CT-PTNB for diagnosis of pulmonary malignancy is acceptable but fairly low compared to previous studies.
{"title":"Diagnostic accuracy of percutaneous transthoracic needle biopsy among peripheral pulmonary lesions: a multicenter observational study.","authors":"Reza Basiri, Farzad Sharifnezhad, Amir H Jafarian, Sara Samadi, Amirreza Zarghi","doi":"10.1097/MS9.0000000000002539","DOIUrl":"10.1097/MS9.0000000000002539","url":null,"abstract":"<p><strong>Introduction: </strong>The diagnosis of peripheral pulmonary lesions (PPL) poses a significant challenge, prompting the widespread utilization of various modalities to ensure the precision in diagnosis. This study aims to assess the diagnostic accuracy of computed tomography-guided percutaneous transthoracic needle biopsy (CT-PTNB) in the context of pulmonary malignancy.</p><p><strong>Methods and materials: </strong>This multicenter retrospective observational study, included 1317 cases of CT-PTNB performed on adult patients with PPLs from January 2018 to December 2022 in Mashhad, Iran. The pathology results of CT-PTNB from 94 cases were compared to the definitive pathology results obtained through methods such as surgery to assess the sensitivity, specificity, and overall accuracy of CT-PTNB in diagnosing of pulmonary malignancy.</p><p><strong>Results: </strong>CT-PTNB exhibits an accuracy of 82.98%, with sensitivity and specificity rates of 75.41 and 91.43%, respectively. This study underscores the issue of false-negative results in CT-PTNB and underscores the importance of integrating clinical, radiological, and additional diagnostic modality to guide diagnostic decisions.</p><p><strong>Conclusion: </strong>In this large-scale multicenter study, the accuracy of CT-PTNB for diagnosis of pulmonary malignancy is acceptable but fairly low compared to previous studies.</p>","PeriodicalId":8025,"journal":{"name":"Annals of Medicine and Surgery","volume":"86 10","pages":"5762-5766"},"PeriodicalIF":1.7,"publicationDate":"2024-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11444528/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142364121","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-09-10eCollection Date: 2024-10-01DOI: 10.1097/MS9.0000000000002541
Xingcheng Zhu, Shi Fu, Junhao Chen
{"title":"Reevaluating the association between cholecystectomy and gastroesophageal reflux disease: recommendations for enhanced Mendelian randomization analysis.","authors":"Xingcheng Zhu, Shi Fu, Junhao Chen","doi":"10.1097/MS9.0000000000002541","DOIUrl":"10.1097/MS9.0000000000002541","url":null,"abstract":"","PeriodicalId":8025,"journal":{"name":"Annals of Medicine and Surgery","volume":"86 10","pages":"6358-6359"},"PeriodicalIF":1.7,"publicationDate":"2024-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11444601/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142364139","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Introduction and importance: Purulent pericarditis is an uncommon complication of Streptococcus pneumoniae, which commonly occurs in an immunocompromised state such as HIV and can lead to life-threatening complications such as cardiac tamponade and potentially death if untreated. Early identification, pericardiocentesis, and general measures such as antibiotics and anti-inflammatory medications can be life-saving.
Case presentation: The authors present a case of a 64-year-old male with HIV who presented with clinical symptoms suggestive of pericarditis. Chest imaging revealed multifocal airspace diseases and moderate pericardial effusion. He had worsening lactic acidosis, and bedside point-of-care ultrasound showed pericardial effusion with features suggestive of cardiac tamponade. His lactic acidosis improved with emergency pericardiocentesis. Blood and pericardial fluid cultures revealed Streptococcus pneumoniae. He was further treated with intravenous antibiotics, colchicine, and ibuprofen.
Clinical discussion: Although Streptococcus pneumoniae is a common etiology of community-acquired pneumonia (CAP), it has not been cited as the leading cause of pericarditis or pericardial effusion. In immunocompromised patients, it is necessary to consider a broad differential diagnosis as an etiology of acute chest pain, as it may be challenging to differentiate pleuritic and pericarditic chest pain from clinical presentation only. Moreover, infectious etiology of acute pericarditis and pericardial effusion should be considered in this patient population, especially those with HIV. At the same time, it is crucial to promptly identify and treat cardiac tamponade to prevent further deterioration.
Conclusion: This case provides insight into the diagnosis and management of CAP and its potential complication of purulent pericarditis and cardiac tamponade in immunocompromised patients.
导言和重要性:化脓性心包炎是肺炎链球菌的一种不常见的并发症,通常发生在免疫力低下的人群(如艾滋病患者)中,如不及时治疗,可导致心脏填塞等危及生命的并发症,甚至可能导致死亡。早期发现、心包穿刺以及抗生素和消炎药等一般措施可以挽救生命:作者介绍了一例 64 岁男性艾滋病感染者的病例,他的临床症状提示患有心包炎。胸部影像学检查发现多灶性气腔病变和中度心包积液。他的乳酸酸中毒症状不断加重,床旁护理点超声检查显示心包积液,并提示有心脏填塞的特征。紧急心包穿刺术后,他的乳酸酸中毒症状有所好转。血液和心包积液培养发现了肺炎链球菌。他接受了静脉抗生素、秋水仙碱和布洛芬的进一步治疗:尽管肺炎链球菌是社区获得性肺炎(CAP)的常见病因,但它并不是心包炎或心包积液的主要病因。对于免疫力低下的患者,有必要将广泛的鉴别诊断作为急性胸痛的病因,因为仅从临床表现来区分胸膜炎性胸痛和心包炎性胸痛可能具有挑战性。此外,对于这类患者,尤其是艾滋病毒感染者,应考虑急性心包炎和心包积液的感染性病因。同时,及时发现和治疗心脏填塞也至关重要,以防止病情进一步恶化:本病例为免疫功能低下患者诊断和治疗 CAP 及其潜在并发症化脓性心包炎和心脏压塞提供了启示。
{"title":"Purulent pericarditis and cardiac tamponade in HIV: a case report on a dreaded complication of <i>Streptococcus pneumoniae</i>.","authors":"Laxman Wagle, Parmartha Basnyat, Anuj Timshina, Rashmita Regmi, Lakpa Diku Sherpa, Sishir Poudel","doi":"10.1097/MS9.0000000000002552","DOIUrl":"10.1097/MS9.0000000000002552","url":null,"abstract":"<p><strong>Introduction and importance: </strong>Purulent pericarditis is an uncommon complication of <i>Streptococcus pneumoniae</i>, which commonly occurs in an immunocompromised state such as HIV and can lead to life-threatening complications such as cardiac tamponade and potentially death if untreated. Early identification, pericardiocentesis, and general measures such as antibiotics and anti-inflammatory medications can be life-saving.</p><p><strong>Case presentation: </strong>The authors present a case of a 64-year-old male with HIV who presented with clinical symptoms suggestive of pericarditis. Chest imaging revealed multifocal airspace diseases and moderate pericardial effusion. He had worsening lactic acidosis, and bedside point-of-care ultrasound showed pericardial effusion with features suggestive of cardiac tamponade. His lactic acidosis improved with emergency pericardiocentesis. Blood and pericardial fluid cultures revealed <i>Streptococcus pneumoniae</i>. He was further treated with intravenous antibiotics, colchicine, and ibuprofen.</p><p><strong>Clinical discussion: </strong>Although <i>Streptococcus pneumoniae</i> is a common etiology of community-acquired pneumonia (CAP), it has not been cited as the leading cause of pericarditis or pericardial effusion. In immunocompromised patients, it is necessary to consider a broad differential diagnosis as an etiology of acute chest pain, as it may be challenging to differentiate pleuritic and pericarditic chest pain from clinical presentation only. Moreover, infectious etiology of acute pericarditis and pericardial effusion should be considered in this patient population, especially those with HIV. At the same time, it is crucial to promptly identify and treat cardiac tamponade to prevent further deterioration.</p><p><strong>Conclusion: </strong>This case provides insight into the diagnosis and management of CAP and its potential complication of purulent pericarditis and cardiac tamponade in immunocompromised patients.</p>","PeriodicalId":8025,"journal":{"name":"Annals of Medicine and Surgery","volume":"86 10","pages":"6311-6316"},"PeriodicalIF":1.7,"publicationDate":"2024-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11444538/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142364136","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}